Side-by-side comparison of AI visibility scores, market position, and capabilities
CA AI corporate travel management via email/chat with McKinsey 30K+ bookings at 20% of US/Canada travel; YC W22 $4M with BCD Travel partnership and BTN Innovation Faceoff winner competing with Navan and SAP Concur.
SkyLink is a California-based AI-powered corporate travel management platform — backed by Y Combinator (W22) with $4 million raised from Abstract Ventures, BBQ Capital, Ethos Capital, Gemini Frontier Fund, YC, and 12 other investors — enabling enterprise employees to book and manage business travel through conversational interfaces (email and chat) rather than traditional travel management portals, achieving major deployments including McKinsey & Company (30,000+ bookings since March 2025, representing 20% of McKinsey's US/Canada corporate travel) and a strategic partnership with BCD Travel for large-scale North America deployment announced in July 2025. SkyLink won BTN Group's 2024 Innovation Faceoff Judges' Choice award, the corporate travel industry's most prestigious startup recognition.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.